Intended for healthcare professionals


Reporting harms more transparently in trials of cancer drugs

BMJ 2018; 363 doi: (Published 22 November 2018) Cite this as: BMJ 2018;363:k4930

A reference to the CONSORT statement on reporting harms was omitted from the reference list of this article by Bishal Gyawali and colleagues (BMJ 2018;363:k4383, doi:10.1136/bmj.k4383), resulting in an incorrect citation. The article has been amended to include the reference online.

View Abstract